Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 6 | 4 |
| List of Tables | 8 | 1 |
| List of Figures | 9 | 1 |
| Pricing and Reimbursement in Brazil - Introduction | 10 | 1 |
| Pricing and Reimbursement in Brazil - Overview | 11 | 26 |
| Trends in Population and Life Expectancy | 11 | 1 |
| Population of Brazil | 11 | 1 |
| Comparison of Population amongst BRIC Nations and the US | 12 | 1 |
| Life Expectancy | 13 | 1 |
| Socio-Economic and Demographic Trends | 14 | 1 |
| Shift in Demographics | 14 | 1 |
| Aging Index | 15 | 1 |
| Rise in Personal Disposable Income | 16 | 1 |
| Per Capita Personal Disposable Income | 17 | 1 |
| Disease Burden | 18 | 2 |
| Healthcare in Brazil | 20 | 1 |
| Healthcare Expenditure in Brazil | 20 | 1 |
| Total Healthcare Expenditure as Percentage of Gross Domestic Product (GDP) | 20 | 1 |
| Public Healthcare Expenditure Compared to Total Health Expenditure in Brazil | 21 | 2 |
| Out-of-Pocket Health Expenditure as Percentage of Private Healthcare Expenditure | 23 | 2 |
| Comparative Analysis | 25 | 1 |
| Total Healthcare Expenditure as Percentage of GDP, Brazil, Russia, India and China (BRIC) and the US, 2006-2009 | 25 | 1 |
| Public Health Expenditure as % of GDP, Brazil, Russia, India and China (BRIC) and the US, 2010-2050 | 26 | 1 |
| Public Health Expenditure as Percentage of Total Healthcare Expenditure, Brazil, Russia, India and China (BRIC) and the US, 2006-2009 | 27 | 1 |
| Per Capita Total Health Expenditure, Brazil, Russia, China and India (BRIC), 2006-2009 | 28 | 1 |
| Per Capita Public Health Expenditure, Brazil, Russia, China and India (BRIC), 2006-2009 | 29 | 1 |
| Out-of-Pocket Expenditure as % of Private Health Expenditure, Brazil, Russia, India and China (BRIC) and the US, 2006-2009 | 30 | 1 |
| Healthcare System in Brazil | 31 | 1 |
| Health Workforce and Infrastructure in Brazil | 31 | 1 |
| Physicians | 31 | 2 |
| Nursery and Midwifery Personnel | 33 | 1 |
| Dentistry Personnel | 34 | 1 |
| Pharmacist | 35 | 1 |
| Hospital Infrastructure | 36 | 1 |
| Pricing and Reimbursement in Brazil - Introduction to Pharmaceutical Market of Brazil | 37 | 5 |
| Market Size and Market Forecasts | 37 | 1 |
| Pharmaceutical Market Sub-sectors | 38 | 1 |
| Pharmaceutical Market Share by Therapy Area | 39 | 1 |
| Opportunities and Challenges | 40 | 1 |
| Drivers and Opportunities | 40 | 1 |
| Challenges | 41 | 1 |
| Pricing and Reimbursement in Brazil - Healthcare Regulation | 42 | 8 |
| Introduction | 42 | 1 |
| Current Regulatory Framework | 42 | 1 |
| Ag ncia Nacional de Vigil ncia Sanit ria (ANVISA) | 42 | 2 |
| Drug Approval Process | 44 | 1 |
| Drug Registration Process | 45 | 1 |
| Patents and Generics (IPR) | 46 | 1 |
| Health Insurance Coverage | 47 | 1 |
| Public Insurance | 47 | 1 |
| Private Insurance | 47 | 1 |
| Coverage | 47 | 1 |
| CNSP | 48 | 1 |
| SUSEP | 48 | 2 |
| Pricing and Reimbursement in Brazil - Pricing | 50 | 3 |
| Pricing Policies | 50 | 1 |
| Annual Price Adjustments | 51 | 1 |
| Price - Setting Authorities | 51 | 1 |
| Ministry of Health (MOH) | 51 | 1 |
| Ag ncia Nacional de Vigil ncia Sanit ria (ANVISA) | 52 | 1 |
| National Agency for Supplementary Health (ANS) | 52 | 1 |
| Pricing and Reimbursement in Brazil - Reimbursement | 53 | 7 |
| The Reimbursement Process | 53 | 3 |
| SUS Sistema nico de Sa de (Unified Health System) | 56 | 1 |
| Health Technology Assessment (HTA) in Brazil s Public Health System | 57 | 1 |
| Objectives of HTA | 58 | 1 |
| Department of Science and Technology (Departamento de Ciencia e Technologia - DECIT) | 59 | 1 |
| Scope of Action | 59 | 1 |
| National Policy on Health Technology Management | 59 | 1 |
| Appendix | 60 | 4 |
| Market Definitions | 60 | 1 |
| Abbreviations | 60 | 1 |
| Sources | 61 | 1 |
| Research Methodology | 61 | 3 |
| Healthcare System | 62 | 1 |
| Methodology | 62 | 1 |
| Sources of Coverage | 62 | 1 |
| Pharmaceutical Regulations | 62 | 1 |
| Methodology | 62 | 1 |
| Sources of Coverage | 62 | 1 |
| Pricing of Pharmaceutical Drugs | 62 | 1 |
| Methodology | 62 | 1 |
| Sources of Coverage | 62 | 1 |
| Reimbursement of Pharmaceutical Drugs | 62 | 1 |
| Methodology | 62 | 1 |
| Sources of Coverage | 62 | 1 |
| Pricing and Reimbursement in Major Therapy Areas | 63 | 1 |
| Methodology | 63 | 1 |
| Sources of Coverage | 63 | 1 |
| Contact Us | 63 | 1 |
| Disclaimer | 63 | 1 |